Dr. Karim Chamie, MD

Dr. Chamie practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Chamie's NPI, 1962478420, was assigned on February 24, 2006. Dr. Chamie graduated from Keck School of Medicine of USC in 2003. Dr. Chamie holds California license A89655.

Dr. Chamie's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Chamie's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Chamie is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Chamie to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chamie practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Chamie's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Chamie is board certified in urology by the American Board of Urology. Dr. Chamie is licensed in California.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney cysts, kidney removal surgery, prostate surgery, transurethral procedures and urinary endoscopy among the conditions Dr. Chamie treats.

CMS data shows 5,848 Medicare services from Dr. Chamie across 19 procedure codes in 2024, for 565 Medicare patients. Medicare paid $254,636 for them.

CMS counts 565 Medicare patients who saw Dr. Chamie in 2024. The largest group is 65 to 74, with 266 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chamie's median patient age at 71, with 28% women.

In 2024, Dr. Chamie wrote 358 Medicare Part D claims for 141 patients. 83% of them were for generic drugs. CMS names the drug for 258 of them, across 6 drugs with 11 or more claims each, at $60,058 in total drug cost. In 2023, CMS named 196 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Chamie for performance year 2024, reported as part of a group. Dr. Chamie accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chamie as offering telehealth. CMS counts 23 procedures of prostate resection by Dr. Chamie, more than 85% of the clinicians it reports for that procedure.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 48 papers to Dr. Chamie, published from 2013 to 2025. 2016 was the busiest year, with 14. The most frequent topics are BCG Vaccine and Urinary Bladder Neoplasms. Dr. Chamie has published most often in Urol Oncol. Dr. Chamie's most frequent co-authors are Nicholas Murray Donin, MD, Allan Pantuck, MD and Arie Belldegrun, MD.

Dmand AI links Dr. Chamie to 7 clinical trials, 2 of them phase 1/2 studies. 4 are still active or recruiting. Conditions studied include Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms and Carcinoma, Transitional Cell. ImmunityBio, Inc. sponsors the most, 2.

CMS Open Payments shows 257 general payments to Dr. Chamie from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Urogen Pharma, Inc. paid the most, $146,633. It also lists 4 research payments totaling $47,012 in 2020.

Dmand AI lists 2 awards for Dr. Chamie.

Dr. Chamie graduated from Keck School of Medicine of USC in 2003. Dr. Chamie is a member of ACS, ASCO, AUA and Society of Urologic Oncology.

Dr. Chamie is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.